Concepedia

Katharina Wiest

KW

Statistics

Publications

17

Citations

2K

H-Index

15

Active since

2011

Affiliations

CoDa Therapeutics (United States)(Current)

National Institute on Drug Abuse

VA Puget Sound Health Care System

Oregon Health & Science University

University of California, Los Angeles

Katharina Wiest is an author at CoDa Therapeutics (United States) specializing in substance use disorders, pharmacology, and medicine.

Publications per year

2011–2022

17

Publications

17

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

Yih‐Ing Hser, Andrew J. Saxon, David Huang et al. · Addiction · 2013 · 457 citations · Full text

, , +17

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Barbara R. Haight, Susan M. Learned, Céline M. Laffont et al. · The Lancet · 2019 · 284 citations

, , +11

Bupropion and Naltrexone in Methamphetamine Use Disorder

Madhukar H. Trivedi, Robrina Walker, Walter Ling et al. · New England Journal of Medicine · 2021 · 263 citations · Full text

, , +16

Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial

Yih‐Ing Hser, Elizabeth Evans, David Huang et al. · Addiction · 2015 · 216 citations · Full text

, , +11

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

Kevin M. Gray, Susan C. Sonne, Erin A. McClure et al. · Drug and Alcohol Dependence · 2017 · 155 citations · Full text

, , +11

1–5 of 17